Use of TCR α
Immune reconstitution
Primary immune deficiency
TCR α+β+/CD19+–depleted haploidentical HSCT
Journal
Journal of clinical immunology
ISSN: 1573-2592
Titre abrégé: J Clin Immunol
Pays: Netherlands
ID NLM: 8102137
Informations de publication
Date de publication:
07 2019
07 2019
Historique:
received:
24
01
2019
accepted:
17
05
2019
pubmed:
7
6
2019
medline:
1
7
2020
entrez:
8
6
2019
Statut:
ppublish
Résumé
Allogeneic hematopoietic stem cell transplantation (HSCT) is curative for many patients with primary immune deficiency (PID). Haploidentical donors have historically been associated with higher rates of graft-versus-host disease (GvHD) and graft failure. Use of T cell receptor (TCR) α
Identifiants
pubmed: 31172381
doi: 10.1007/s10875-019-00648-x
pii: 10.1007/s10875-019-00648-x
doi:
Substances chimiques
Antigens, CD19
0
Receptors, Antigen, T-Cell, alpha-beta
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
505-511Références
Bone Marrow Transplant. 2008 Oct;42(8):523-7
pubmed: 18622413
Semin Hematol. 2010 Jan;47(1):79-85
pubmed: 20109615
Pediatr Clin North Am. 2010 Feb;57(1):207-37
pubmed: 20307719
Pediatrics. 2010 May;125(5):866-75
pubmed: 20435707
J Allergy Clin Immunol. 2010 Sep;126(3):602-10.e1-11
pubmed: 20673987
Blood. 2012 Mar 22;119(12):2949-55
pubmed: 22308292
Blood. 2014 Jul 31;124(5):822-6
pubmed: 24869942
J Pediatr Hematol Oncol. 2015 Jul;37(5):e295-300
pubmed: 25985240
Biol Blood Marrow Transplant. 2015 Nov;21(11):1955-62
pubmed: 26187864
Adv Hematol. 2016;2016:4025073
pubmed: 26904122
Blood. 2016 Jun 23;127(25):3281-90
pubmed: 27099148
Biol Blood Marrow Transplant. 2017 Mar;23(3):483-490
pubmed: 28039080
J Allergy Clin Immunol. 2018 Apr;141(4):1417-1426.e1
pubmed: 28780238
J Clin Immunol. 2018 Aug;38(6):727-732
pubmed: 30105620
Bone Marrow Transplant. 1995 Jun;15(6):825-8
pubmed: 7581076